59 research outputs found

    Adjusted hazard ratio of pulmonary embolism found in the follow-up period associated with ACOS and prescriptions of ICSs and OSs.

    No full text
    <p>Adjusted hazard ratio of pulmonary embolism found in the follow-up period associated with ACOS and prescriptions of ICSs and OSs.</p

    Comparison of demographics and history of comorbidity between ACOS and non-ACOS cohorts.

    No full text
    Comparison of demographics and history of comorbidity between ACOS and non-ACOS cohorts.</p

    The adjusted hazard ratio of tuberculosis in different risk factors.

    No full text
    <p>The adjusted hazard ratio of tuberculosis in different risk factors.</p

    Incidence rate and adjusted hazard ratio of pulmonary embolism between ACOS and non-ACOS cohorts stratified by each comorbidity types.

    No full text
    Incidence rate and adjusted hazard ratio of pulmonary embolism between ACOS and non-ACOS cohorts stratified by each comorbidity types.</p

    The cumulative incidence of pulmonary embolism in asthma–COPD overlap syndrome (ACOS) (dashed line) and non-ACOS cohorts (solid line).

    No full text
    <p>The cumulative incidence of pulmonary embolism in asthma–COPD overlap syndrome (ACOS) (dashed line) and non-ACOS cohorts (solid line).</p

    The adjusted hazard ratio of tuberculosis associated with number of outpatient visits and hospitalizations per year due to COPD or asthma exacerbation.

    No full text
    <p>The adjusted hazard ratio of tuberculosis associated with number of outpatient visits and hospitalizations per year due to COPD or asthma exacerbation.</p

    Comparison of demographics and comorbidity between ACOS and non-ACOS cohorts.

    No full text
    <p>Comparison of demographics and comorbidity between ACOS and non-ACOS cohorts.</p

    Adjusted hazard ratio of tuberculosis found in the follow-up period associated with ACOS and prescriptions of SABAs, SAMAs, LAMAs, LABAs, or ICSs.

    No full text
    <p>Adjusted hazard ratio of tuberculosis found in the follow-up period associated with ACOS and prescriptions of SABAs, SAMAs, LAMAs, LABAs, or ICSs.</p

    Incidence and adjusted hazard ratio of tuberculosis stratified by sex, age, and comorbidity between ACOS and non-ACOS cohorts.

    No full text
    <p>Incidence and adjusted hazard ratio of tuberculosis stratified by sex, age, and comorbidity between ACOS and non-ACOS cohorts.</p

    The cumulative incidence of tuberculosis in asthma–COPD overlap syndrome (ACOS) (dashed line) and non-ACOS cohorts (solid line).

    No full text
    <p>The cumulative incidence of tuberculosis in asthma–COPD overlap syndrome (ACOS) (dashed line) and non-ACOS cohorts (solid line).</p
    • …
    corecore